TY - JOUR
T1 - Polytetrafluoroethylene bifurcation prosthesis for the treatment of aortoiliac atherosclerotic occlusive disease
T2 - A 5-year clinical trial
AU - Motta, G.
AU - Ratto, G. B.
AU - Secco, G. B.
AU - Fardelli, R.
AU - Beretta, E.
PY - 1990
Y1 - 1990
N2 - During the period of 1984-1986, the authors have implanted 13 polytetrafluoroethylene (PTFE) bifurcation grafts for the treatment of aortoiliac occlusive disease. The patients were 12 men and 1 woman, their mean age being 60.05 ± 6.3 years. The indications for aortoiliac reconstruction were limiting claudication in 6 patients and rest pain in 7 patients. Follow-up lasted forty-six ± seven months and included physical examination, measurement of the ankle-brachial pressure index, and ultrasonography. Arteriography was performed exclusively in sympatomatic patients. No operative deaths or major complications were recorded. Graft limb occlusion occurred in 2 patients, eight and twenty-two months after surgery, respectively. The five-year patency rate was 85%. During follow-up, there was no evidence of graft infection, kinking, stenosis, or dilatation. Neither perigraft seroma nor anastomotic aneurysm developed.
AB - During the period of 1984-1986, the authors have implanted 13 polytetrafluoroethylene (PTFE) bifurcation grafts for the treatment of aortoiliac occlusive disease. The patients were 12 men and 1 woman, their mean age being 60.05 ± 6.3 years. The indications for aortoiliac reconstruction were limiting claudication in 6 patients and rest pain in 7 patients. Follow-up lasted forty-six ± seven months and included physical examination, measurement of the ankle-brachial pressure index, and ultrasonography. Arteriography was performed exclusively in sympatomatic patients. No operative deaths or major complications were recorded. Graft limb occlusion occurred in 2 patients, eight and twenty-two months after surgery, respectively. The five-year patency rate was 85%. During follow-up, there was no evidence of graft infection, kinking, stenosis, or dilatation. Neither perigraft seroma nor anastomotic aneurysm developed.
UR - http://www.scopus.com/inward/record.url?scp=0025333884&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025333884&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:0025333884
VL - 24
SP - 335
EP - 339
JO - Vascular Surgery
JF - Vascular Surgery
SN - 0042-2835
IS - 5
ER -